医学
胎盘早剥
因素五莱顿
子痫前期
怀孕
宫内生长受限
血栓性
活化蛋白C抗性
人口
血栓形成
产科
静脉血栓形成
胎儿
内科学
遗传学
环境卫生
生物
作者
Dena Bloomenthal,Marie‐France Delisle,Francine Tessier,Peter W. K. Tsang
摘要
Factor V Leiden (FVL) is a newly discovered genetic mutation that impairs one of the body's naturally occurring anticoagulation systems. The result is resistance to activated protein C and a predisposition to thrombosis. FVL is the most common cause of primary and recurrent venous thromboembolism in the pregnant and nonpregnant state. The FVL gene is common in the general population and transmitted in an autosomal dominant fashion. When FVL is combined with the prothrombotic state of pregnancy, the result is an increased propensity to manifest a number of pregnancy complications. These include recurrent pregnancy loss and stillbirth, severe and early-onset preeclampsia, placental abruption and possibly, intrauterine growth restriction. It remains unknown whether thromboprophylaxis is effective in ameliorating these pregnancy complications. The current literature and management recommendations are highlighted in this article.
科研通智能强力驱动
Strongly Powered by AbleSci AI